Therapeutic Group

Indication Dosage

Trimetazidine is a medication primarily indicated for the treatment of angina pectoris, a cardiovascular condition characterized by chest pain or discomfort due to reduced blood flow to the heart muscle. It works by improving the efficiency of the heart's energy production process, thereby reducing the frequency and severity of angina attacks. Trimetazidine is often prescribed as an adjunct therapy alongside other standard treatments for angina, helping to enhance overall symptom management and improve the quality of life for individuals with this condition.

Prophylactic Treatment Of Angina Pectoris, Adjunct Symptomatic Treatment Of Vertigo And Tinnitus, Adjunct Treatment Of Visual Disorders Of A Circulatory Origin: 

• Adults: 20 Mg 3 Times Daily, With Meals, Or 35 Mg 2 Times Daily, With Meals. 
• Children: Not Recommended.

Content

Pregnancy

Caution Advised

Stability

Contra Indications

Precautions

Lactation

Side Effects